期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CEREBELLUM LetPub Score 6.2
50 ratings
Rate
Reputation 7.5 Influence 5.1 Speed 7.0 | ||||||||||||||||||||
期刊簡稱 | CEREBELLUM | ||||||||||||||||||||
ISSN | 1473-4222 | ||||||||||||||||||||
E-ISSN | 1473-4230 | ||||||||||||||||||||
h-index | 61 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 11.10%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://www.springer.com/12311 | ||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/cere | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Springer US | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||
創刊年 | 2002 | ||||||||||||||||||||
每年文章數 | 130每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 33.51% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1473-4222%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CEREBELLUM] 的評論 | 撰寫評論 |
作者: 归元冰桃 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-25 18:15:16 評論於 Hello, do you have any results?(0) 讚! | 归元冰桃 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:56:48 評論於 We suggest dividing the discussion of research limitations into three parts: (1) presenting research limitations; (2) explaining research limitations in detail; and (3) proposing future research directions or improvement measures. Discussing research limitations in this order can help you clearly identify research gaps without compromising the quality and validity of the study(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:49:14 評論於 The relationship between the findings of this study and relevant theories; Limitations or shortcomings of your research; Practical significance and application value of this study; Suggestions for future research(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 20:36:09 評論於 What can we generally discuss in a discussion?(0) 讚! | 陶宜三岁啦 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 19:37:24 評論於 How to write about limitations in a discussion?(0) 讚! | 平原文波 |
作者: 平原依珊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-10-05 18:58:02 評論於 Review Speed: 2.0 | Submission Acceptance Rate: 75.0 Experience Sharing: Previously rejected once and asked us to resubmit... Submitted on May 7th, received feedback on July 6th... Given three months for revisions. Accepted on October 5th(0) 讚! | 平原依珊 |
作者: 平原依珊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-05-10 14:31:58 評論於 Review Speed: 1.0 Experience Sharing: The first submission was rejected, with a review duration of 15 days. There were two reviewers, one thought minor revisions were sufficient for acceptance, while the other raised a few questions. In the end, the editor rejected our submission, but encouraged us to resubmit after revisions. We resubmitted on May 7th, and on May 9th, it entered the "under review" status. Feeling quite nervous, I hope for a positive outcome(0) 讚! | 平原依珊 |
作者: 彬丽小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-03-14 13:32:53 評論於 First time投, hoping for a good outcome(0) 讚! | 彬丽小可爱 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us